Non-small cell lung cancer (NSCLC) represents the most common and fatal type of primary
lung malignancies. NSCLC is often diagnosed at later stages and requires systemic …

Background: Frailty is a common geriatric syndrome and is described as a limited ability to
compensate and recover from stressors. Lung cancer is largely diagnosed in old age, when …

Objectives: In this study we retrospectively analyzed the prognostic factors of patients with
advanced non-small cell lung cancer (NSCLC). Methods: Clinical data of 112 patients with …

Purpose The purpose of this study is to investigate the efficacy and safety of immune
checkpoint inhibitors (ICIs) or plus with chemotherapy in older patients. Methods We …

Age is but one significant prognostic factor in lung cancer, influencing survival, treatment
response, and outcomes. This narrative review synthesizes findings from searches of 11 …

This work focused on the clinical efficacy of chrono-chemotherapy and conventional
chemotherapy on patients with non-small cell lung cancer (NSCLC), providing a theoretical …

The present study explored the risk factors associated with radiotherapy in seniors
diagnosed with limited-stage small cell lung cancer (LS-SCLC) to construct and validate a …

Objectives: Non-small cell lung (NSCLC) cancer is usually seen in elderly patients. The
impact of over 70 age on the survival of patients with NSCLC has not been studied. This …

Introduction Despite recent advances in NSCLC treatment, specific data on the elderly
population remain limited. In this post hoc subgroup analysis of the East Asia S-1 Trial in …

Background The role of platinum-based chemotherapy (PBC) for the treatment of older
patients with non-small cell lung cancer (NSCLC) is still a matter of debate, despite the …